After compiling statistics for over 28 million adults under 60 years of age, a nationwide French cohort study found that:

 

Quote

Young and middle-age adults who had at least one dose of a COVID-19 mRNA vaccine were less likely to die of any cause in the following 4 years compared with those who weren't vaccinated ...

 

Link not requiring registration:

 

https://archive.ph/me3mp

 

Link usable with a free registration:

 

https://www.medpagetoday.com/infectiousdisease/covid19vaccine/118840

45 minutes ago, GroveHillWanderer said:

After compiling statistics for over 28 million adults under 60 years of age, a nationwide French cohort study found that:

 

 

Link not requiring registration:

 

https://archive.ph/me3mp

 

Link usable with a free registration:

 

https://www.medpagetoday.com/infectiousdisease/covid19vaccine/118840

There was a similar study and the result arrived at the same conclusion and as the mRNA vaccine has been studied since 1990, it is now being studied for use as an anti cancer drug after encouraging results in that field.

They seem to be a very impartial publication coming out of NY. Trust the science. From their publication, quote:

 

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2005–2025 MedPage Today, LLC, a Ziff Davis company. All rights reserved.

 

Then you have a look at the Ziff Davis website, you can find some gems like this one, quote:

 

Ziff Davis is a vertically focused digital media and internet company whose portfolio includes leading
brands in technology, shopping, gaming and entertainment, connectivity, health, cybersecurity, and
martech. We are committed to operating sustainably and limiting any damaging effects our operations
may have on climate change and biodiversity, even as our direct operations generate relatively
insubstantial greenhouse gas emissions. As such, Ziff Davis received validation of its science-based
greenhouse gas emissions reduction targets from the Science Based Targets initiative (SBTi), a
partnership between the CDP, the United Nations Global Compact, World Resources Institute, and the
Worldwide Fund for Nature.

 

Ziff Davis aims to reduce its: ● Absolute Scope 1 and 2 GHG emissions by 50% by 2030 from a 2021 base year ● Scope 3 GHG emissions from purchased goods & services and capital goods 51.6% per USD value added within the same timeframe

 

 

Furthermore, and, in accordance with our Environmental Policy, we aim to: ● Perform an annual GHG inventory process, assured by an independent third-party, to measure our company-wide GHG emissions ● Provide transparency on our climate change efforts by responding annually to CDP ● Continue our ongoing efforts to reduce the emissions generated in our operations to become more efficient and ensure our services are delivered sustainably ● Integrate environmental risk evaluation criteria, including climate change, into the due diligence process for mergers and acquisitions ● Work closely with our largest suppliers and vendors, whom we encourage to measure and disclose their own greenhouse gas emissions on an annual basis ● Ensure all direct and indirect engagement activities are aligned with global environmental treaties such as the Paris Agreement ● Encourage our employees to engage in sustainability efforts (including by participating in our Sustainability Council) ● Educate employees on identifying and altering what they can do individually to be more sustainable in their everyday lives We believe these efforts will help reduce climate change and promote biodiversity. Ziff Davis undertakes these efforts across all of its brands and subsidiaries, in connection with the company’s business, strategy, and financial planning. Ziff Davis’ sustainability team and Board of Directors are charged with maintaining these commitments, and assessing and managing climate change-related risks in ongoing operations.

COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France

 

Key Points

Question  Are COVID-19 mRNA vaccines associated with the long-term risk of all-cause mortality?

 

Findings  In this cohort study including 22.7 million vaccinated individuals and 5.9 million unvaccinated individuals, vaccinated individuals had a 74% lower risk of death from severe COVID-19 and no increased risk of all-cause mortality over a median follow-up of 45 months.

 

Meaning  These national-level results found no increased risk of 4-year all-cause mortality in individuals aged 18 to 59 years vaccinated against COVID-19, further supporting the safety of the mRNA vaccines that are being widely used worldwide.

 

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842305